Membership

RFP, CGN and CGA Opportunities

The Alliance is a community dedicated to connecting healthcare education professionals to promote best practices that improve patient care. To help achieve this, we collect information on research proposals and grants offered through other healthcare-related organizations. If your company is interested in posting a request for grant applications, please contact the Alliance Business Office at acehp@acehp.org

American Academy of Dermatology

The Academy bestows a number of prestigious awards to recognize the contributions of individuals to the specialty as well as offering various grants and scholarships to assist recipients in furthering their areas of study and broadening knowledge in the field of dermatology.

Program for Innovative Continuing Medical Education in Dermatology (PICMED)

The program was established to facilitate dermatologists' continuing education through support and development of innovative continuing medical education programs.

Available grants

  • Multi-year grant: Applicants may request up to $50,000 (direct costs only) for a two (2) year funding period.  2nd year funding will be contingent on 1st year milestones being met. 
  • Single-year grant: Applicants may request up to $10,000 (direct costs only) for a one (1) year project period. 

For more information regarding PICMED, please visit the AAD website.


Bristol-Myers Squibb

Bristol-Myers Squibb accepts funding requests within the following therapeutic areas of interest. As areas of interest and funding consideration may change periodically, please consult this website frequently. Please note that international funding opportunities may differ.

  • Cardiovascular
  • Immunoscience
  • Oncology
  • Virology
  • Genetically Defined / Rare Diseases

View Request for Proposals / for Education


Indivior

Indivior supports independent medical education activities that provide for an increased understanding of scientific, clinical, or healthcare issues related to the company’s therapeutic areas of interest. 

Therapeutic areas of interest:

  • Opioid Use Disorder
  • Schizophrenia

To view open RFPs and complete details regarding grant submission, please visit the following site on a regular basis: grants.indivior.com


Insmed Incorporated

Insmed has funding to support independent accredited education intended to improve clinician knowledge, competence, and performance in the diagnosis and treatment of patients with Nontuberculous Mycobacterial (NTM) Lung Disease. Please refer to www.insmed.com/grants-giving/ for grant submission requirements. For additional questions about the CGA process please contact Insmed Medical Education at grants@insmed.com. Grant submissions should align to the specifications in the downloadable CGA.

Therapeutic Areas: Pulmonology/Infectious Disease
Nontuberculous Mycobacterial (NTM) Lung Disease
Focus Area: Local and Regional Education Activities

Submission Deadline: Rolling submissions accepted for 2018/2019
Download Call for Grants

Therapeutic Areas: Pulmonology/Infectious Disease
Nontuberculous Mycobacterial (NTM) Lung Disease
Focus Area: Education Activities associated with 2019 ATS and other Medical Society Conferences

Submission Deadline: at least 60 days prior to the requestors need for funding commitment, or based on society deadlines.
Download Call for Grants


Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)

The Centers for Medicare & Medicaid Services (CMS) recognizes the benefits of measure development by external stakeholders with specific knowledge of clinician and patient perspectives and needs, such as clinical specialty societies, clinical professional organizations, patient advocacy organizations, educational institutions, independent research organizations, health systems, and other entities. 

On March 2, 2018 CMS published the “Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program” on Grants.gov. The purpose of this Funding Opportunity is to provide technical and funding assistance in the form of cooperative agreements to entities to develop, improve, update, or expand quality measures for use in the Quality Payment Program (QPP). 

For more information and to see the ‘Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program’ search by the title or the Catalog of Federal Domestic Assistance (CFDA) number, 93.986 on Grants.gov.


Regeneron and Sanofi Genzyme Alliance

The Regeneron and Sanofi Genzyme Alliance seeks to close important medical educational gaps with regard to advanced cutaneous squamous cell carcinoma (CSCC) through consideration of grant proposals for 2019-2020 independent medical education activities. Target audiences include dermatologists, oncologists, Mohs surgeons, head and neck surgeons, and advanced-level practitioners via live and enduring distribution channels; please refer to the Request for Proposal for further details.

To view open RFPs and complete details, please visit this webpage


Pfizer Independent Grants for Learning & Change (IGLC)

The mission of Pfizer Independent Grants for Learning & Change is to partner with the global healthcare community to improve patient outcomes in areas of mutual interest through support of measurable learning and change strategies. The Joint Commission is an independent, not-for-profit organization that accredits and certifies nearly 21,000 health care organizations and programs in the United States. 

To view open RFPs and complete details, please visit this webpage.


Sanofi Genzyme 

Request for Regional Educational Programs at ASH Highlights in North America 2020 locations. These educational grants are intended to support qualified organizations in the areas of interest above, but not directly related to our therapies or products. To respond to this RFP, please complete the Independent Medical Education application at https://sgrants.envisionpharma.com/vt_sgrants.

Click here to open RFP. 

When entering proposal into the website, please reference the following:

Therapeutic Area: Genetic Disease
Area of Interest: Gaucher Disease and Niemann-Pick Disease (A and B)
RFP Name: 'ASH Highlights - GD NP 2019'

Please note that you must answer the question, “Are you responding to an RFP” and select “'ASH Highlights - GD NP 2019'” from the RFP dropdown panel within the grant portal upon submitting your application for this RFP.

Should you have any questions, please contact Lindsey Bigda at lindsey.bigda@sanofi.com.


Sanofi Genzyme 

You are invited to submit a grant proposal to address the educational need outlined in the attached document.

Please review and return your completed proposal via the Sanofi U.S. Grant Website at https://sgrants.envisionpharma.com/vt_sgrants/ by 5 pm ET on Friday, May 24, 2019.

If a submission is not completed by this date, your proposal will not be accepted.

When entering proposal into the website, please reference the following:

Therapeutic Area:      Immunology

Area of Interest:        Atopic Dermatitis

RFP Name:                 AD-Global-2019-1

Please note that an applicant may be ineligible to receive a grant in response to this request for proposal (RFP) if the applicant has performed any services under contract with Sanofi U.S. during the last 12 months in connection with a consultant meeting or an advisory board meeting in the same therapeutic area as this RFP.  If the applicant has performed such services, please forward a copy of the contract immediately, prior to responding to the RFP, so that we can determine your eligibility.  If not, please acknowledge this in your application writing.

Please note that you must answer the question, “Are you responding to an RFP” and select “AD-Global-2019-1” from the RFP dropdown panel within the grant portal upon submitting your application for this RFP.

Submission instructions are available on the website. If you have a content question, please contact Sharon Barnett at Sharon.Barnett2@sanofi.com.


Seattle Genetics

Seattle Genetics invites you to submit grant applications to identify and address the educational needs in the therapeutic area of Breast Cancer. The purpose of this Call for Grant Applications (CGA) is to encourage organizations to submit grant applications for an in-depth independent educational needs assessment(s) designed to assess and understand the rapidly evolving educational needs of HCPs responsible for treatment decisions for patients with hormone receptor-positive 2 metastatic breast cancer (HER2+ mBC), including:

  • Understanding of current and future treatment options in patients with HER 2+ mBC with or without brain metastases
  • Awareness and understanding of emerging therapeutic options for patients with HER 2+ mBC who have failed two or more lines of therapy
  • Awareness and understanding of differences in mechanism of action, efficacy, tolerability, and safety profiles of novel agents in HER2+ mBC

The deadline to respond is April 12, 2019. To view the CGA, please click here.


Shionogi Inc.

Shionogi accepts funding requests within the following therapeutic areas of interest.

  • Gram negative multidrug resistant infectious disease (ID)
  • Thrombocytopenia associated with chronic liver disease (CLD)
  • Opioid-induced Constipation (OIC)

The call for grants (CFG) opportunities will change on a quarterly basis.  Please consult our website to identify current opportunities.


Tesaro

TESARO is seeking to support a healthcare improvement program that addresses the educational gap for access and utilization of PARPi in the recurrent maintenance setting with an initiative evaluating the impact of quality-focused interventions on assessment, treatment and patient care in a local or national healthcare institution or system.
The purpose of this call for grants is to facilitate the translation of evidence-based medicine into measurable clinical
outcomes.

Medical education providers interested in responding to this CFG should send a letter of intent with a description of the proposed QI program to grants@tesarobio.com by Friday, March 8, 2019.
Download RFP